Cardium Therapeutics (CXM)
Cardium Therapeutics News
Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
PR Newswire about 11 days agoSAN DIEGO, May 17, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced that Christopher J. Reinhard, Chairman & CEO will present a corporate overview and participate in a Regenerative ...
New Star Analyst Rankings for Cardium Therapeutics, Inc. Comm
about 12 days agoInPlay: Cardium Therapeutics announces new catheter-based methods significantly boost cardiac gene delivery
about 12 days agoCardium Reports New Catheter-Based Methods Significantly Boost Cardiac Gene Delivery In Late-Breaking Presentation at 2012 American Society of Gene & Cell Therapy Meeting
PR Newswire about 12 days agoSAN DIEGO, May 16, 2012 /PRNewswire/ -- Cardium Therapeutics (CXM) today announced a late-breaking poster presentation at the American Society of Gene & Cell Therapy (ASGCT) 15th Annual Meeting ...
CARDIUM THERAPEUTICS, INC. Files SEC form 10-Q, Quarterly Report
about 13 days agoSmall caps round-up: Cello, DDD, Kewill...
about 13 days agoCardium Therapeutics (CXM) Enters Excellagen Agreement with Angel Biomedical
Street Insider about 13 days agoCardium Therapeutics (CXM) Reports In-Line Q1 Loss of 2c/Share
Street Insider about 13 days agoCardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
Benzinga about 13 days agoCardium Presents First Quarter 2012 Financial Results and Recent Developments
PR Newswire about 13 days agoSAN DIEGO, May 15, 2012 /PRNewswire/ -- Cardium Therapeutics (CXM) today presented its financial results for the first quarter ended March 31, 2012, and other recent developments.(Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO ...
Angel Biotechnology - Angel Biomedical Ltd announces supply agreement
about 14 days agoSmall Biotech Companies Look to Benefit From Improvement of U.S. Patent System
Marketwire about 17 days agoNEW YORK, NY-- - In recent months the Biotech Industry has become a hotbed of Merger and Acquisition activity and speculation. As large pharmaceuticals face major patent expirations in 2012 they have looked ...
Annual Report for Cardium Therapeutics
about 27 days agoCardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
PR Newswire about 39 days agoSAN DIEGO, April 19, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) is currently exhibiting its new FDA-cleared Excellagen ® professional-use, syringe-based wound care product for the management ...
You may also be interested in these CXM related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CXM | 0.2375 | -0.00 | -0.25% | 28.41M |
| CXH | 10.60 | +0.00 | +0.00% | |
| CXDC | 4.93 | -0.05 | -1.00% | 234.32M |
| CXA | 24.42 | +0.02 | +0.08% | |
| CX | 5.47 | +0.00 | +0.00% | 5.797B |
| CWTR | 0.84 | +0.02 | +2.44% | 102.15M |
| CVS | 44.98 | -0.19 | -0.42% | 58.77B |
| CVRT | 21.71 | +0.00 | +0.00% | |
| CVR | 18.70 | -0.07 | -0.37% | 18.14M |
| CVO | 1.72 | +0.02 | +1.18% | 109.10M |
